ZnO nanofluids for the improved cytotoxicity and cellular uptake of doxorubicin

Objective(s): Combination anticancer therapy holds promise for improving the therapeutic efficacy of chemotherapy drugs such as doxorubicin (DOX) as well as decreasing their dose-limiting side effects. Overcoming the side effects of doxorubicin (DOX) is a major challenge to the effective treatment o...

Full description

Bibliographic Details
Main Authors: Safoura Soleymani, Razieh Jalal
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2018-01-01
Series:Nanomedicine Journal
Subjects:
Online Access:http://nmj.mums.ac.ir/article_10052_32fe370d54196b61937afedaf93004cc.pdf